B-cell hyperactivity in primary Sjögren's syndrome

References

• Fox RI. Sjogren's syndrome. Lancet 2005;366(9482):321-31
   PubMed Web of Science ®Google Scholar
• Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome. Nat Rev Rheumatol 2010;6(9):529-37
   PubMed Web of Science ®Google Scholar
• Hjelmervik TO, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52(5):1534-44
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci USA 2006;103(8):2770-5
   PubMed Web of Science ®Google Scholar
• Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, et al. Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol 2008;38(7):2024-33
   PubMed Web of Science ®Google Scholar
• Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet 2013;45(11):1284-92
   PubMed Web of Science ®Google Scholar
• Igoe A, Scofield RH. Autoimmunity and infection in Sjogren's syndrome. Curr Opin Rheumatol 2013;25(4):480-7
   PubMed Web of Science ®Google Scholar
• Inoue H, Mishima K, Yamamoto-Yoshida S, et al. Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjogren's syndrome. J Immunol 2012;188(9):4654-62
   PubMed Web of Science ®Google Scholar
• Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun 2010;35(3):256-64
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Kapsogeorgou EK. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2010;35(3):219-24
   PubMed Web of Science ®Google Scholar
• Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol 2013;9(9):544-56
   PubMed Web of Science ®Google Scholar
• Moerman RV, Arends S, Meiners PM, et al. EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial. Ann Rheum Dis 2014;73(2):472-4
   PubMed Web of Science ®Google Scholar
• Rawlings DJ, Schwartz MA, Jackson SW, Meyer-Bahlburg A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol 2012;12(4):282-94
   PubMed Web of Science ®Google Scholar
• Kil LP, Hendriks RW. Aberrant B cell selection and activation in systemic lupus erythematosus. Int Rev Immunol 2013;32(4):445-70
   PubMed Web of Science ®Google Scholar
• Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010;34(4):400-7
   PubMed Web of Science ®Google Scholar
• Pijpe J, Meijer JM, Bootsma H, et al. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjogren's syndrome. Arthritis Rheum 2009;60(11):3251-6
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Brokstad KA, Oijordsbakken G, et al. Salivary glands of primary Sjogren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 2011;13(1):R2
   PubMed Web of Science ®Google Scholar
• Mitsias DI, Tzioufas AG, Veiopoulou C, et al. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol 2002;128(3):562-8
   PubMed Web of Science ®Google Scholar
• Horvath S, Nazmul-Hossain AN, Pollard RP, et al. Systems analysis of primary Sjogren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Res Ther 2012;14(6):R238
   PubMed Web of Science ®Google Scholar
• Hernandez-Molina G, Michel-Peregrina M, Hernandez-Ramirez DF, et al. Chemokine saliva levels in patients with primary Sjogren's syndrome, associated Sjogren's syndrome, pre-clinical Sjogren's syndrome and systemic autoimmune diseases. Rheumatology (Oxford) 2011;50(7):1288-92
   PubMed Web of Science ®Google Scholar
• Lee YJ, Scofield RH, Hyon JY, et al. Salivary chemokine levels in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2010;49(9):1747-52
   PubMed Web of Science ®Google Scholar
• Yeruva S, Ramadori G, Raddatz D. NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis 2008;23(3):305-17
   PubMed Web of Science ®Google Scholar
• Ogawa N, Ping L, Zhenjun L, et al. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome. Arthritis Rheum 2002;46(10):2730-41
   PubMed Web of Science ®Google Scholar
• Roescher N, Tak PP, Illei GG. Cytokines in Sjogren's syndrome. Oral Dis 2009;15(8):519-26
   PubMed Web of Science ®Google Scholar
• Muehlinghaus G, Cigliano L, Huehn S, et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 2005;105(10):3965-71
   PubMed Web of Science ®Google Scholar
• Amft N, Curnow SJ, Scheel-Toellner D, et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum 2001;44(11):2633-41
   PubMed Web of Science ®Google Scholar
• Vanbervliet B, Bendriss-Vermare N, Massacrier C, et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 2003;198(5):823-30
   PubMed Web of Science ®Google Scholar
• Bave U, Nordmark G, Lovgren T, et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52(4):1185-95
   PubMed Web of Science ®Google Scholar
• Corsiero E, Bombardieri M, Manzo A, et al. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol Lett 2012;145(1-2):62-7
   PubMed Web of Science ®Google Scholar
• Barone F, Bombardieri M, Manzo A, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005;52(6):1773-84
   PubMed Web of Science ®Google Scholar
• Barone F, Bombardieri M, Rosado MM, et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 2008;180(7):5130-40
   PubMed Web of Science ®Google Scholar
• Xanthou G, Polihronis M, Tzioufas AG, et al. “Lymphoid” chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjogren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 2001;44(2):408-18
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011;12(7):639-46
   PubMed Web of Science ®Google Scholar
• Peters A, Pitcher LA, Sullivan JM, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 2011;35(6):986-96
   PubMed Web of Science ®Google Scholar
• Chen Z, O'Shea JJ. Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008;41(2):87-102
   PubMed Web of Science ®Google Scholar
• Grogan JL, Ouyang W. A role for Th17 cells in the regulation of tertiary lymphoid follicles. Eur J Immunol 2012;42(9):2255-62
   PubMed Web of Science ®Google Scholar
• Lim HW, Lee J, Hillsamer P, Kim CH. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 2008;180(1):122-9
   PubMed Web of Science ®Google Scholar
• Katsifis GE, Rekka S, Moutsopoulos NM, et al. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 2009;175(3):1167-77
   PubMed Web of Science ®Google Scholar
• Sakai A, Sugawara Y, Kuroishi T, et al. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008;181(4):2898-906
   PubMed Web of Science ®Google Scholar
• Ciccia F, Guggino G, Rizzo A, et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis 2012;71(2):295-301
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Larsson P, Tengner P, et al. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scand J Immunol 2002;55(4):336-42
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum 2003;48(11):3187-201
   PubMed Web of Science ®Google Scholar
• Kramer JM, Klimatcheva E, Rothstein TL. CXCL13 is elevated in Sjogren's syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol 2013;94(5):1079-89
   PubMed Web of Science ®Google Scholar
• Badr G, Borhis G, Lefevre EA, et al. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008;111(5):2744-54
   PubMed Web of Science ®Google Scholar
• Hansen A, Lipsky PE, Dorner T. B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007;9(4):218
   PubMed Web of Science ®Google Scholar
• Hansen A, Odendahl M, Reiter K, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2002;46(8):2160-71
   PubMed Web of Science ®Google Scholar
• Hansen A, Reiter K, Ziprian T, et al. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjogren's syndrome. Arthritis Rheum 2005;52(7):2109-19
   PubMed Web of Science ®Google Scholar
• Risselada AP, Looije MF, Kruize AA, et al. The role of ectopic germinal centers in the immunopathology of primary Sjogren's syndrome: a systematic review. Semin Arthritis Rheum 2013;42(4):368-76
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Skarstein K, Jonsson R, Brun JG. Serological implications of germinal center-like structures in primary Sjogren's syndrome. J Rheumatol 2007;34(10):2044-9
   PubMed Web of Science ®Google Scholar
• Le Pottier L, Devauchelle V, Fautrel A, et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009;182(6):3540-7
   PubMed Web of Science ®Google Scholar
• Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome. Ann Rheum Dis 2011;70(8):1363-8
   PubMed Web of Science ®Google Scholar
• Allen CD, Ansel KM, Low C, et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004;5(9):943-52
   PubMed Web of Science ®Google Scholar
• Bombardieri M, Barone F, Humby F, et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome. J Immunol 2007;179(7):4929-38
   PubMed Web of Science ®Google Scholar
• Stott DI, Hiepe F, Hummel M, et al. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J Clin Invest 1998;102(5):938-46
   PubMed Web of Science ®Google Scholar
• Zuckerman NS, Hazanov H, Barak M, et al. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J Autoimmun 2010;35(4):325-35
   PubMed Web of Science ®Google Scholar
• Kaschner S, Hansen A, Jacobi A, et al. Immunoglobulin Vlambda light chain gene usage in patients with Sjogren's syndrome. Arthritis Rheum 2001;44(11):2620-32
   PubMed Web of Science ®Google Scholar
• Hamza N, Bootsma H, Yuvaraj S, et al. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjogren's syndrome after B cell depletion therapy. Ann Rheum Dis 2012;71(11):1881-7
   PubMed Web of Science ®Google Scholar
• Vinuesa CG, Sanz I, Cook MC. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009;9(12):845-57
   PubMed Web of Science ®Google Scholar
• Tengner P, Halse AK, Haga HJ, et al. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren's syndrome. Arthritis Rheum 1998;41(12):2238-48
   PubMed Web of Science ®Google Scholar
• Halse A, Harley JB, Kroneld U, Jonsson R. Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjogren's syndrome. Clin Exp Immunol 1999;115(1):203-7
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Skarstein K, Oijordsbakken G, Brokstad KA. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjogren's syndrome. Clin Exp Immunol 2013;172(2):228-37
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Brokstad KA, Jakobsen K, et al. Low number of memory B cells in the salivary glands of patients with primary Sjogren's syndrome. Autoimmunity 2012;45(7):547-55
   PubMed Web of Science ®Google Scholar
• Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009;9(7):491-502
   PubMed Web of Science ®Google Scholar
• Lahiri A, Pochard P, Le Pottier L, et al. The complexity of the BAFF TNF-family members: implications for autoimmunity. J Autoimmun 2012;39(3):189-98
   PubMed Web of Science ®Google Scholar
• Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002;109(1):59-68
   PubMed Web of Science ®Google Scholar
• Pers JO, D'Arbonneau F, Devauchelle-Pensec V, et al. Is periodontal disease mediated by salivary BAFF in Sjogren's syndrome? Arthritis Rheum 2005;52(8):2411-14
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Szodoray P, Jellestad S, et al. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005;25(3):189-201
   PubMed Web of Science ®Google Scholar
• Pollard RP, Abdulahad WH, Vissink A, et al. Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Ann Rheum Dis 2013;72(1):146-8
   PubMed Web of Science ®Google Scholar
• Pers JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005;1050:34-9
   PubMed Web of Science ®Google Scholar
• Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 2003;62(2):168-71
   PubMed Web of Science ®Google Scholar
• Daridon C, Devauchelle V, Hutin P, et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2007;56(4):1134-44
   PubMed Web of Science ®Google Scholar
• Lavie F, Miceli-Richard C, Quillard J, et al. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J Pathol 2004;202(4):496-502
   PubMed Web of Science ®Google Scholar
• Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther 2006;8(2):R51
   PubMed Web of Science ®Google Scholar
• Ittah M, Miceli-Richard C, Gottenberg JE, et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur J Immunol 2008;38(4):1058-64
   PubMed Web of Science ®Google Scholar
• Brkic Z, Maria NI, van Helden-Meeuwsen CG, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis 2013;72(5):728-35
   PubMed Web of Science ®Google Scholar
• Lavie F, Miceli-Richard C, Ittah M, et al. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome. Scand J Immunol 2008;67(2):185-92
   PubMed Web of Science ®Google Scholar
• Yoshimoto K, Tanaka M, Kojima M, et al. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjogren's syndrome. Arthritis Res Ther 2011;13(5):R170
   PubMed Web of Science ®Google Scholar
• Darce JR, Arendt BK, Wu X, Jelinek DF. Regulated expression of BAFF-binding receptors during human B cell differentiation. J Immunol 2007;179(11):7276-86
   PubMed Web of Science ®Google Scholar
• Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol 2011;32(8):388-94
   PubMed Web of Science ®Google Scholar
• Abu-Rish EY, Amrani Y, Browning MJ. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF. Rheumatology (Oxford) 2013;52(7):1190-201
   PubMed Web of Science ®Google Scholar
• He B, Santamaria R, Xu W, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 2010;11(9):836-45
   PubMed Web of Science ®Google Scholar
• Ozcan E, Rauter I, Garibyan L, et al. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation. J Allergy Clin Immunol 2011;128(3):601-9. e1-4
   PubMed Web of Science ®Google Scholar
• Chu VT, Berek C. Immunization induces activation of bone marrow eosinophils required for plasma cell survival. Eur J Immunol 2012;42(1):130-7
   PubMed Web of Science ®Google Scholar
• Braun D, Caramalho I, Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int Immunol 2002;14(4):411-19
   PubMed Web of Science ®Google Scholar
• Fairfax KA, Kallies A, Nutt SL, Tarlinton DM. Plasma cell development: from B-cell subsets to long-term survival niches. Semin Immunol 2008;20(1):49-58
   PubMed Web of Science ®Google Scholar
• Xu W, Joo H, Clayton S, et al. Macrophages induce differentiation of plasma cells through CXCL10/IP-10. J Exp Med 2012;209(10):1813-23. S1-2
   PubMed Web of Science ®Google Scholar
• Konforte D, Simard N, Paige CJ. IL-21: an executor of B cell fate. J Immunol 2009;182(4):1781-7
   PubMed Web of Science ®Google Scholar
• Ettinger R, Sims GP, Fairhurst AM, et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005;175(12):7867-79
   PubMed Web of Science ®Google Scholar
• Bryant VL, Ma CS, Avery DT, et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 2007;179(12):8180-90
   PubMed Web of Science ®Google Scholar
• Ding BB, Bi E, Chen H, et al. IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells. J Immunol 2013;190(4):1827-36
   PubMed Web of Science ®Google Scholar
• Ettinger R, Sims GP, Robbins R, et al. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol 2007;178(5):2872-82
   PubMed Web of Science ®Google Scholar
• Guerrier T, Youinou P, Pers JO, Jamin C. TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity. J Autoimmun 2012;39(3):173-9
   PubMed Web of Science ®Google Scholar
• Daridon C, Pers JO, Devauchelle V, et al. Identification of transitional type II B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2006;54(7):2280-8
   PubMed Web of Science ®Google Scholar
• Kang KY, Kim HO, Kwok SK, et al. Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther 2011;13(5):R179
   PubMed Web of Science ®Google Scholar
• Maehara T, Moriyama M, Hayashida JN, et al. Selective localization of T helper subsets in labial salivary glands from primary Sjogren's syndrome patients. Clin Exp Immunol 2012;169(2):89-99
   PubMed Web of Science ®Google Scholar
• Tangye SG, Ma CS, Brink R, Deenick EK. The good, the bad and the ugly - TFH cells in human health and disease. Nat Rev Immunol 2013;13(6):412-26
   PubMed Web of Science ®Google Scholar
• Szabo K, Papp G, Barath S, et al. Follicular helper T cells may play an important role in the severity of primary Sjogren's syndrome. Clin Immunol 2013;147(2):95-104
   PubMed Web of Science ®Google Scholar
• Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012;209(7):1241-53
   PubMed Web of Science ®Google Scholar
• Diehl SA, Schmidlin H, Nagasawa M, et al. IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells. Immunol Cell Biol 2012;90(8):802-11
   PubMed Web of Science ®Google Scholar
• Carbone G, Wilson A, Diehl SA, et al. Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis. Int J Biol Sci 2013;9(3):279-88
   PubMed Web of Science ®Google Scholar
• Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008;14(3):109-19
   PubMed Web of Science ®Google Scholar
• Szodoray P, Alex P, Brun JG, et al. Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004;59(6):592-9
   PubMed Web of Science ®Google Scholar
• Pollard RP, Abdulahad WH, Bootsma H, et al. Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome. Ann Rheum Dis 2013;72(12):2028-50
   Web of Science ®Google Scholar
• Fox RI, Kang HI, Ando D, et al. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 1994;152(11):5532-9
   PubMed Web of Science ®Google Scholar
• Lee SY, Han SJ, Nam SM, et al. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients. Am J Ophthalmol 2013;156(2):247-53. e1
   PubMed Web of Science ®Google Scholar
• Daridon C, Guerrier T, Devauchelle V, et al. Polarization of B effector cells in Sjogren's syndrome. Autoimmun Rev 2007;6(7):427-31
   PubMed Web of Science ®Google Scholar
• Hiepe F, Dorner T, Hauser AE, et al. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011;7(3):170-8
   PubMed Web of Science ®Google Scholar
• Chu VT, Berek C. The establishment of the plasma cell survival niche in the bone marrow. Immunol Rev 2013;251(1):177-88
   PubMed Web of Science ®Google Scholar
• Gellrich S, Rutz S, Borkowski A, et al. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjogren's syndrome. Arthritis Rheum 1999;42(2):240-7
   PubMed Web of Science ®Google Scholar
• Hansen A, Gosemann M, Pruss A, et al. Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis Rheum 2004;50(6):1897-908
   PubMed Web of Science ®Google Scholar
• Routsias JG, Goules JD, Charalampakis G, et al. Malignant lymphoma in primary Sjogren's syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 2013;43(2):178-86
   PubMed Web of Science ®Google Scholar
• Morse HC 3rd, Kearney JF, Isaacson PG, et al. Cells of the marginal zone–origins, function and neoplasia. Leuk Res 2001;25:2):169-178
   PubMed Web of Science ®Google Scholar
• Silverman GJ, Goodyear CS. Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat Rev Immunol 2006;6(6):465-75
   PubMed Web of Science ®Google Scholar
• Hamza N, Hersberg U, Kallenberg CG, et al. Immunoglobulin gene analysis reveals altered selective pressures on Ig-producing cells in parotid glands of primary Sjögren's syndrome patients; Submitted
   Google Scholar
• Bohnhorst JO, Bjorgan MB, Thoen JE, et al. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J Immunol 2001;167(7):3610-18
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome. Scand J Immunol 2001;54(4):421-7
   PubMed Web of Science ®Google Scholar
• Abdulahad WH, Meijer JM, Kroese FG, et al. B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjogren's syndrome: a double-blind, placebo-controlled study. Arthritis Rheum 2011;63(4):1116-23
   PubMed Web of Science ®Google Scholar
• Saadoun D, Terrier B, Bannock J, et al. Expansion of autoreactive unresponsive CD21-/low B cells in Sjogren's syndrome-associated lymphoproliferation. Arthritis Rheum 2013;65(4):1085-96
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Bjorgan MB, Thoen JE, et al. Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration. Clin Immunol 2002;103(1):79-88
   PubMed Web of Science ®Google Scholar
• Kato K, Chu P, Takahashi S, et al. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Exp Hematol 2007;35(3):434-42
   PubMed Web of Science ®Google Scholar
• Loenen WA, De Vries E, Gravestein LA, et al. The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur J Immunol 1992;22(2):447-55
   PubMed Web of Science ®Google Scholar
• Binard A, Le Pottier L, Devauchelle-Pensec V, et al. Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis 2009;68(9):1447-52
   PubMed Web of Science ®Google Scholar
• d'Arbonneau F, Pers JO, Devauchelle V, et al. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjogren's syndrome. Arthritis Rheum 2006;54(1):115-26
   PubMed Web of Science ®Google Scholar
• Pers JO, Youinou P. Are the B cells cast with the leading part in the Sjogren's syndrome scenario? Oral Dis 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Tobon GJ, Renaudineau Y, Hillion S, et al. The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 2010;62(11):3447-56
   PubMed Web of Science ®Google Scholar
• Tobon GJ, Saraux A, Gottenberg JE, et al. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 2013;65(12):3218-27
   PubMed Web of Science ®Google Scholar
• Kil LP, de Bruijn MJ, van Nimwegen M, et al. Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood 2012;119(16):3744-56
   PubMed Web of Science ®Google Scholar
• Nordmark G, Wang C, Vasaitis L, et al. Association of genes in the NF-kappaB pathway with antibody-positive primary Sjogren's syndrome. Scand J Immunol 2013;78(5):447-54
   PubMed Web of Science ®Google Scholar
• Nordmark G, Kristjansdottir G, Theander E, et al. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome. Genes Immun 2011;12(2):100-9
   PubMed Web of Science ®Google Scholar
• Sun F, Li P, Chen H, et al. Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren's syndrome in Han Chinese. J Hum Genet 2013;58(7):475-9
   PubMed Web of Science ®Google Scholar
• Cherukuri A, Cheng PC, Sohn HW, Pierce SK. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 2001;14(2):169-79
   PubMed Web of Science ®Google Scholar
• Smith AJ, Gordon TP, Macardle PJ. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjogren's syndrome. Tissue Antigens 2004;63(3):255-9
   PubMedGoogle Scholar
• Wu HJ, Bondada S. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J Clin Immunol 2009;29(1):12-21
   PubMed Web of Science ®Google Scholar
• Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjogren syndrome patients according to serological profiles. J Autoimmun 2012;39(1-2):15-26
   PubMed Web of Science ®Google Scholar
• Jonsson R, Theander E, Sjostrom B, et al. Autoantibodies present before symptom onset in primary Sjogren syndrome. JAMA 2013;310(17):1854-5
   PubMed Web of Science ®Google Scholar
• Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64(4):475-87
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61(6):554-8
   PubMed Web of Science ®Google Scholar
• Routsias JG, Tzioufas AG. Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest 2010;40(11):1026-36
   PubMed Web of Science ®Google Scholar
• Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. J Autoimmun 2012;39(1-2):4-8
   PubMed Web of Science ®Google Scholar
• Lisi S, Sisto M, Lofrumento D, et al. Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies. Clin Exp Med 2010;10(3):199-203
   PubMed Web of Science ®Google Scholar
• Ronnblom L, Eloranta ML. The interferon signature in autoimmune diseases. Curr Opin Rheumatol 2013;25(2):248-53
   PubMed Web of Science ®Google Scholar
• Berggren O, Hagberg N, Weber G, et al. B lymphocytes enhance interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 2012;64(10):3409-19
   PubMed Web of Science ®Google Scholar
• Varin MM, Guerrier T, Devauchelle-Pensec V, et al. In Sjogren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 2012;11(4):252-8
   PubMed Web of Science ®Google Scholar
• Fillatreau S. Cytokine-producing B cells as regulators of pathogenic and protective immune responses. Ann Rheum Dis 2013;72(Suppl 2):ii80-4
   PubMed Web of Science ®Google Scholar
• Luu VP, Vazquez MI, Zlotnik A. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 2014;47(1):1-12
   PubMed Web of Science ®Google Scholar
• Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008;20(3):332-8
   PubMed Web of Science ®Google Scholar
• Furuzawa-Carballeda J, Hernandez-Molina G, Lima G, et al. Peripheral regulatory cells immunophenotyping in Primary Sjogren's Syndrome: a cross-sectional study. Arthritis Res Ther 2013;15(3):R68
   PubMed Web of Science ®Google Scholar
• Hirotani M, Niino M, Fukazawa T, et al. Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J Neuroimmunol 2010;221(1-2):95-100
   PubMed Web of Science ®Google Scholar
• Barr TA, Shen P, Brown S, et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012;209(5):1001-10
   PubMed Web of Science ®Google Scholar
• Jenks SA, Sanz I. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun Rev 2009;8(3):209-13
   PubMed Web of Science ®Google Scholar
• Shlomchik MJ. Activating systemic autoimmunity: B's, T's, and tolls. Curr Opin Immunol 2009;21(6):626-33
   PubMed Web of Science ®Google Scholar
• Green NM, Marshak-Rothstein A. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 2011;23(2):106-12
   PubMed Web of Science ®Google Scholar
• Zheng L, Zhang Z, Yu C, Yang C. Expression of Toll-like receptors 7, 8, and 9 in primary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):844-50
   PubMed Web of Science ®Google Scholar
• Guerrier T, Le Pottier L, Devauchelle V, et al. Role of Toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. J Autoimmun 2012;39(1-2):69-76
   PubMed Web of Science ®Google Scholar
• Meijer JM, Meiners PM, Vissink A, et al. Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010;62(4):960-8
   PubMed Web of Science ®Google Scholar
• Dass S, Bowman SJ, Vital EM, et al. Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 2008;67(11):1541-4
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Cinquetti G, Larroche C, et al. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis 2013;72(6):1026-31
   PubMed Web of Science ®Google Scholar
• Adler S, Korner M, Forger F, et al. Evaluation of histological, serological and clinical changes in response to abatacept treatment of primary Sjogren's syndrome: a pilot study. Arthritis Care Res (Hoboken) 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Meiners PM, Vissink A, Kroese FG, et al. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). Ann Rheum Dis Ann Rheum Dis 2014. [Epub ahead of print]
   Google Scholar
• Puri KD, Di Paolo JA, Gold MR. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies. Int Rev Immunol 2013;32(4):397-427
   PubMed Web of Science ®Google Scholar
• Macauley MS, Pfrengle F, Rademacher C, et al. Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J Clin Invest 2013;123(7):3074-83
   PubMed Web of Science ®Google Scholar
• Kroese FG, Bootsma H. Biomarkers: new biomarker for Sjogren's syndrome–time to treat patients. Nat Rev Rheumatol 2013;9(10):570-2
   PubMed Web of Science ®Google Scholar
• Hammi AR, Al-Hashimi IH, Nunn ME, Zipp M. Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren's syndrome. J Oral Pathol Med 2005;34(4):198-203
   PubMed Web of Science ®Google Scholar
• Toker E, Yavuz S, Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br J Ophthalmol 2004;88(3):384-7
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Seror R, Miceli-Richard C, et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjogren's syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS One 2013;8(5):e59868
   PubMed Web of Science ®Google Scholar